Replacement of surgical castration by GnRH inhibition for rat prostate androgen receptor preparations.
Ashby
J
J
Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, UK. John.Ashby@Syngenta.com
Lefevre
P A
PA
D000726:Androgen Antagonists / Q000494:pharmacology; D000818:Animals; D001667:Binding, Competitive; D001681:Biological Assay / Q000379:methods*; D003600:Cytosol / Q000187:drug effects / Q000378:metabolism; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D066298:In Vitro Techniques; D008297:Male; D015741:Metribolone / Q000494:pharmacology; D009842:Oligopeptides / Q000494:pharmacology; D009919:Orchiectomy; D011467:Prostate / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D011944:Receptors, Androgen / Q000378:metabolism*; D045165:Testosterone Congeners / Q000494:pharmacology; D014316:Tritium
D000726:Androgen Antagonists; D009842:Oligopeptides; D011944:Receptors, Androgen; D045165:Testosterone Congeners; D014316:Tritium; D015741:Metribolone; D007987:Gonadotropin-Releasing Hormone; C057022:iturelix; C084350:antarelix